03/29/2011 白天灌水

zhyuan04

set tight stop for my NQ long at 2317. (I bought at 2297).

Simpletrader

there is slight problem with apple today.

chickencoop

plmt 发表于 2011-3-29 15:36
充分证明这游击队员也不是好当的！

en, need quick hands. for us slow hands, follow the leaders...

天天向上

Simpletrader 发表于 2011-3-29 15:38
there is slight problem with apple today.

什么问题呢?

CoolMax

加油，先冲过1320再说。

CoolMax

回复 天天向上 的帖子

暂时落后大盘。

Cobra

http://bbs.cobrasmarketview.com/ ... 82&p=4414#p4414

Rosemary1

CoolMax 发表于 2011-3-29 13:00
回复 Rosemary1 的帖子

从1249起，至少缺个五浪。

yes, 3rd push.

wxstone

回复 CoolMax 的帖子

铁道游击队的特长就是把乘客都赶下车

mtguyla

132 高地近在眼前!

CoolMax

wxstone 发表于 2011-3-29 15:49
回复 CoolMax 的帖子

铁道游击队的特长就是把乘客都赶下车

天天向上

回复 CoolMax 的帖子

我也想知道为什么今天aapl不涨, 看不出什么, 除了一个amzn开始cloud service的news以外.

terranmn

SEC CHARGES FDA CHEMIST WITH INSIDER TRADING AHEAD OF DRUG APPROVAL ANNOUNCEMENTS

The Securities and Exchange Commission today charged a U.S. Food and Drug Administration (FDA) chemist with insider trading on confidential information about upcoming announcements of FDA drug approval decisions, generating more than $3.6 million in illicit profits and avoided losses.

The SEC alleges that Cheng Yi Liang illegally traded in advance of at least 27 public announcements about FDA drug approval decisions involving 19 publicly traded companies. Some announcements concerned the FDA’s approval of new drugs while others concerned negative FDA decisions. In each instance, he traded in the same direction as the announcement. Liang went to great lengths to conceal his insider trading. He traded in seven brokerage accounts, none of which were in his name. One belonged to his 84-year-old mother who lives in China.

Cobra

http://bbs.cobrasmarketview.com/ ... 82&p=4417#p4417

ppteam

Apr market new high.

ppteam

This Fri is bullish.

oda

Thank you COBRA AND HTERS, I'll see you tomorrow!

CoolMax

回复 天天向上 的帖子

有恐怖袭击的事件。

ppteam

回复 ppteam 的帖子

ppteam

回复 ppteam 的帖子

YM afternoon is not as long as in the morning, 5 points away from MM target, that's 0.5 ES point, consider it's reached.